Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly E Caudle

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|May 25, 2021
Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 GenotypeJohn Henry McDermott, Joshua Wolf, Keito Hoshitsuki, et al.
Clinical Pharmacology and Therapeutics|February 26, 2019
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine TherapyJacob T Brown, Jeffrey R Bishop, Katrin Sangkuhl, et al.
Clinical and Translational Science|October 25, 2019
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working GroupKelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 22, 2016
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, et al.
Clinical Pharmacology and Therapeutics|December 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S GenotypesStephen G Gonsalves, Robert T Dirksen, Katrin Sangkuhl, et al.
Clinical Pharmacology and Therapeutics|September 1, 2022
Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD GenotypeRoseann S Gammal, Munir Pirmohamed, Andrew A Somogyi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 15, 2025
Toward an integrated resource for pharmacogenomics (PGx): Survey findings from the genomic medicine communitiesClarissa J Klein, Li Gong, Kelly E Caudle, et al.
Journal of the American College of Clinical Pharmacy : JACCP|November 25, 2024
Decoding Pharmacogenomic Test Interpretation and Application to Patient CareRoseann S Donnelly, Larisa H Cavallari, Jeannine S McCune, et al.
Clinical Pharmacology and Therapeutics|February 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen TherapyMatthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, et al.
Clinical Pharmacology and Therapeutics|December 17, 2024
Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic EthnicityMaud Maillard, Jenny Q Nguyen, Wenjian Yang, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|May 25, 2021
Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 GenotypeJohn Henry McDermott, Joshua Wolf, Keito Hoshitsuki, et al.
Clinical Pharmacology and Therapeutics|February 26, 2019
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine TherapyJacob T Brown, Jeffrey R Bishop, Katrin Sangkuhl, et al.
Clinical and Translational Science|October 25, 2019
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working GroupKelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 22, 2016
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, et al.
Clinical Pharmacology and Therapeutics|December 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S GenotypesStephen G Gonsalves, Robert T Dirksen, Katrin Sangkuhl, et al.
Clinical Pharmacology and Therapeutics|September 1, 2022
Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD GenotypeRoseann S Gammal, Munir Pirmohamed, Andrew A Somogyi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 15, 2025
Toward an integrated resource for pharmacogenomics (PGx): Survey findings from the genomic medicine communitiesClarissa J Klein, Li Gong, Kelly E Caudle, et al.
Journal of the American College of Clinical Pharmacy : JACCP|November 25, 2024
Decoding Pharmacogenomic Test Interpretation and Application to Patient CareRoseann S Donnelly, Larisa H Cavallari, Jeannine S McCune, et al.
Clinical Pharmacology and Therapeutics|February 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen TherapyMatthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, et al.
Clinical Pharmacology and Therapeutics|December 17, 2024
Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic EthnicityMaud Maillard, Jenny Q Nguyen, Wenjian Yang, et al.
Pageof 5